NCT07197957 Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
| NCT ID | NCT07197957 |
| Status | Recruiting |
| Phase | — |
| Sponsor | BayCare Health System |
| Condition | Acute Kidney Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-11 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-11 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the clinical utility of serum cystatin C in early detection of acute kidney injury (AKI).
Eligibility Criteria
Inclusion Criteria: * Subjects ages 18 years and above * Inpatients with CKD (Figure 1) * Order for CT imaging study or coronary angiography with isohexol Omnipaque) contrast media. * Pre and post contrast available * All races and ethnicity of patients are eligible. We expect to analyze approximately equal number of men and women in this study. Exclusion Criteria: * Preexisting dialysis * Patients under the age of 18 years * Pregnancy * Incarcerated individuals * Patients with impaired cognition and unable to follow consent procedures * Recent exposure to CM (within 2 days before/after procedure) * Cardiac shock * Medications that affect biomarkers, including corticosteroids, lfamethoxazoletrimethoprim
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07197957 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07197957 currently recruiting?
Yes, NCT07197957 is actively recruiting participants. Contact the research team at tracy.johns@baycare.org for enrollment information.
Where is the NCT07197957 trial being conducted?
This trial is being conducted at Clearwater, United States, New Port Richey, United States, Safety Harbor, United States, St. Petersburg, United States.
Who is sponsoring the NCT07197957 clinical trial?
NCT07197957 is sponsored by BayCare Health System. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.